Somatostatin in medium-sized aspiny interneurons of striatum is responsible for their preservation in quinolinic acid and N-methyl-D-asparate-induced neurotoxicity

Journal of Molecular Neuroscience

Volumn 35, Issue 3, 2008, Pages 345-354

  Kumar, Ujendra ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Excitotoxicity; NADPH diaphorase; Neuronal culture; Neuroprotection; Somatostatin

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID; NEUTRALIZING ANTIBODY; PERTUSSIS TOXIN; QUINOLINIC ACID; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SOMATOSTATIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; CELL CULTURE; CELL DEATH; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CORPUS STRIATUM; CULTURE MEDIUM; EMBRYO; IMMUNOADSORPTION; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; IMMUNOPOTENTIATION; INTERNEURON; MOLECULAR MECHANICS; NERVE CELL; NERVE CELL DEGENERATION; NERVE CELL NECROSIS; NERVE DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; RAT;

ANIMALS; ANTIBODIES; CELL SURVIVAL; CELLS, CULTURED; CYTOPROTECTION; EXCITATORY AMINO ACID ANTAGONISTS; INTERNEURONS; N-METHYLASPARTATE; NADPH DEHYDROGENASE; NEOSTRIATUM; NERVE DEGENERATION; NEUROTOXINS; OLIGONUCLEOTIDES, ANTISENSE; PERTUSSIS TOXIN; QUINOLINIC ACID; RATS; RECEPTORS, SOMATOSTATIN; SOMATOSTATIN;

EID: 51649104282     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12031-008-9093-3     Document Type: Article

References (48)

1. M. Aarts Y. Liu L. Liu S. Besshoh M. Arudine J. W. Gurd 2002 Treatment of ischemic brain damage by perturbing NMDA receptor-PSD-95 protein interactions Science 298 846 850
2. N. Aronin P. E. Coper L. J. Lorenz 1983 Somatostatin is increased in the basal ganglia in Huntington's disease Annals of Neurology 13 519 526
3. S. J. Augood E. K. McGowan P. C. Emson 1994 Expression of N-methyl-d-aspartate receptor subunit NR1 messenger RNA by identified striatal somatostatin cells Neuroscience 59 7 12
4. M. F. Beal R. J. Ferrante K. J. Swartz N. W. Kowall 1991 Chronic quinolinic acid lesions in rats closely resemble Huntington's disease Journal of Neuroscience 11 1649 1659
5. M. F. Beal N. W. Kowall D. W. Ellison M. F. Mozurek K. J. Swartz J. B. Martin 1986 Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid Nature 321 168 171
6. M. F. Beal N. W. Kowall K. J. Swartz R. J. Ferrante J. B. Martin 1989 Differential sparing of somatostatin-neuropeptide Y and cholinergic neurons following striatal excitotoxin lesions Synapse 3 1 38 47
7. M. F. Beal M. F. Masurek V. T. Tran G. Chattha E. D. Bird M. B. Martin 1985 Reduced numbers of somatostatin receptors in the cerebral cortex in Alzheimer's disease Science 229 289 291
8. G. Bissette L. Cook W. Smith K. C. Dole B. Crain C. B. Nemeroff 1998 Regional neuropeptide pathology in Alzheimer's disease: Corticotropin-releasing factor and somatostatin Journal of Alzheimer's Disease 1 91 105
9. G. Bissette B. Myers 1992 Minireview: Somatostatin in Alzheimer's disease and depression Life Science 51 1389 1410
10. R. J. Boegman A. Parent 1988 Differential sensitivity of neuropeptide Y, somatostatin and NADPH-d containing neurons in rat cortex and striatum to quinolinic acid Brain Research 445 358 362
11. R. J. Boegman Y. Smith A. Parent 1987 Quinolinic acid does not spare striatal neuropeptide Y immunoreactive neurons Brain Research 415 178 183
12. Q. Chen A. Reiner 1996 Cellular distribution of the NMDA receptor NR2A/2B subunits in rat striatum Brain Research 743 346 352
13. P. Davies R. Katzman R. D. Terry 1980 Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer's disease and Alzheimer senile dementia Nature 288 279 280
14. S. W. Davies P. J. Robert 1987 No evidence for preservation of somatostatin-containing neurons after intrastriatal injections of quinolinic acid Nature 327 326 329
15. K. L. Davis M. Davidson R. K. Yang B. M. Davis L. J. Siever R. C. Mohs 1988 CSF somatostatin in Alzheimer's disease, depressed patients, and control subjects Biological Psychiatry 24 710 712
16. D. Dawbarn M. E. De Quidt P. C. Emson 1985 Survival of basal ganglia neuropeptide Y- somatostatin neurons in Huntington's disease Brain Research 340 251 260
17. V. L. Dawson V. M. Kizushi P. L. Huang S. H. Snyder T. M. Dawson 1996 Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase deficient mice Journal of Neuroscience 16 2479 2487
18. R. J. Ferrante N. W. Kowall M. F. Beal E. P. Richardson Jr. E. D. Bird J. B. Martin 1985 Selective sparing of a class of striatal neurons in Huntington's disease Science 230 561 563
19. G. Figueredo Cardenas Q. Chen A. Reiner 1997 Age-dependent differences in survival of striatal somatostatin-NPY-NADPH-diaphorase containing interneurons versus striatal projection neurons after intra-striatal injection of quinolinic acid in rat Exper Neurology 146 444 457
20. G. Forloni E. Lucca N. Angeretti R. Chiesa A. Vezzani 1997 Neuroprotective effect of somatostatin on non-apoptotic NMDA-induced neuronal death: role of cyclic GMP Journal of Neurochemistry 68 1 319 327
21. C. Geci J. How H. Alturahi U. Kumar 2007 β-Amyloid increases the expression of Somatostatin mRNA its accumulation in cortical cultured neurons Journal of Neurochemistry 101 664 673
22. 2+ accumulation in cortical cell culture correlates with subsequent neuronal degeneration Journal of Neuroscience 13 1993 2000
23. B. T. Hope S. R. Vincent 1989 Histochemical characterization of neuronal NADPH-diaphorase Journal of Histochemistry and Cytochemistry 37 653 661
24. P. L. Huang T. M. Dawson D. S. Bredt S. H. Snyder M. C. Fishman 1993 Targeted disruption of neuronal nitric oxide synthase gene Cell 75 1273 1286
25. J. Y. Koh D. W. Choi 1988 Cortical striatal neurons containing NADPH-d or acetylcholinetransferase are selectively resistant to injury by NMDA receptor agonist Brain Research 446 374 378
26. J. -Y. Koh S. Peters D. W. Choi 1986 Neurons containing NADPH-diaphorase are selectively resistant to quinolinate toxicity Science 234 73 76
27. U. Kumar 2004 Characterization of striatal cultures with the effect of QUIN and NMDA Neuroscience Research 49 29 38
28. U. Kumar 2005 Expression of somatostatin receptor subtypes (SSTR1-5) in Alzheimer's disease brain: An immunohistochemical analysis Neuroscience 134 525 538
29. U. Kumar 2007 Colocalization of somatostatin receptor subtypes (SSTR1-5) with somatostatin, tyrosine hydroxylase and NADPH-diaphorase in rat hypothalamus Journal of Comparative Neurology 504 185 205
30. U. Kumar K. Asotra S. C. Patel Y. C. Patel 1997 Expression of NMDA receptor-1 (NR1) and huntingtin in striatal neurons which colocalize somatostatin, neuropeptide Y and NADPH-diaphorase: A double-label histochemical and immunohistochemical study Experimental Neurology 145 412 424
31. J. B. Martin J. F. Gusella 1986 Huntington's disease: Pathogenesis and management New England Journal of Medicine 315 1267 1276
32. S. E. Molchan J. L. Hill R. A. Martinez B. A. Lawlor A. M. Mellow D. R. Rubino 1993 CSF somatostatin in Alzheimer's disease, and major depression: Relationship to hypothalamic-pituitary-adrenal axis and clinical measures Psychoneuroendrocrinol 18 509 519
33. A. Monno M. Rizzi R. Samanin A. Vezzani 1993 Anti-somatostatin antibody enhances the rate of hippocampal kindling Brain Research 602 148 152
34. H. Monyer R. Sprengel R. Schoepjer 1992 Heteromeric NMDA receptors: Molecular and functional distinction of subtypes Science 256 1217 1221
35. C. B. Nemeroff D. L. Knight G. Bissette 1992 Somatostatin: A neuropeptide system pathologically altered in Alzheimer's disease and depression Clinical Neuropharmacology 15 Suppl 311A 312A
36. C. B. Nemeroff W. W. Youngblood A. J. Prange Jr. J. S. Kizer 1983 Regional brain concentrations of neuropeptides in Huntington's chorea and schizophrenia Science 221 972 975
37. C. L. Nilsson A. Brinkmalm L. Minthon K. Blenno R. Ekman 2001 Processing of neuropeptide Y, galanin, and somatostatin in the cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia Peptides 22 2105 2112
38. P. J. Norris H. J. Waldvogel R. L. M. Paul D. R. Love P. C. Emson 1996 Decreased neuronal nitric oxide synthase messenger RNA and somatostatin mRNA in the striatum of Huntington's Disease Neuroscience 72 1037 1047
39. Y. C. Patel J. L. Liu A. Warszynska G. Kent D. N. Papachristou S. C. Patel 1995 Differential stimulation of somatostatin but not neuropeptide Y gene expression by quinolinic acid in cultured cortical neurons Journal of Neurochemistry 65 998 1006
40. S. C. Patel D. N. Papachristou Y. C. Patel 1991 Quinolinic acid stimulates somatostatin gene expression in cultured rat cortical neurons Journal of Neurochemistry 56 1286 1291
41. A. Reiner R. L. Albin K. D. Anderson 1988 Differential loss of striatal projection neurons in Huntington's disease Proceedings of the National Academy of Sciences of the United States of America 85 5733 5737
42. T. Saito N. Iwata S. Tsubuki Y. Takaki J. Takano S. M. Huang 2005 Somatostatin regulates brain amyloid B peptide AB42 through modulation of proteolytic degradation Nature Medicine 11 434 439
43. A. Vezzani R. Serafini M. A. Stassi G. Vigano M. Rizzi R. Samanin 1991 A peptidase-resistant cyclic octapeptide analogue of somatostatin (SMS 201-995) modulates seizure induced by quinolinic acid and kainic acids differently in the rat hippocampus Neuropharmacology 30 345 352
44. S. R. Vincent O. Johansson 1983 Striatal neurons containing both somatostatin- and avian pancreatic polypeptide (APP)-like immunoreactivities and NADPH-diaphorase activity: A light and electron microscopic study Journal of Comparative Neurology 217 264 270
45. H. L. Wang T. Reisine M. Dichter 1990 Somatostatin-14 and somatostatin-28 inhibit calcium current in rat neocortical neurons Neuroscience 38 335 342
46. J. S. Williams I. Berbekar S. Weiss 1991 N-Methyl-d-aspartate evokes the release of somtostatin from striatal interneurons in primary culture Neuroscience 43 437 444
47. A. B. Young J. T. Greenamyre Z. Hollingsworth R. Albin C. D'Amato I. Shoulson 1988 NMDA receptor losses in putamen from patients with Huntington's disease Science 241 981 983
48. M. M. Zeron O. Hansson N. Chen C. L. Wellington B. R. Leavitt P. Brudin 2002 Increased sensitivity to N-methyl-d-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease Neuron 33 849 860